• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

植物疗法诱发的肝细胞毒性:一例报告

Phytotherapy-Induced Hepatocytotoxicity: A Case Report.

作者信息

Malnick Stephen, Abdullah Ali, Maor Yaacov, Neuman Manuela G

机构信息

Department of Internal Medicine C, Kaplan Medical Center, Hebrew University, Rehovot 76100, Israel.

Institute of Gastroenterology and Liver Disease, Kaplan Medical Center, Rehovot 76100, Israel.

出版信息

Curr Issues Mol Biol. 2024 Jul 16;46(7):7548-7557. doi: 10.3390/cimb46070448.

DOI:10.3390/cimb46070448
PMID:39057089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11275310/
Abstract

Herbal and complementary medicine are frequently integrated with conventional medicine. We aim to report a case of severe herbal-induced liver injury (HILI) due to chronic use of green tea and protein shake. We present both clinical and laboratory evidence implicating mitochondrial toxicity and an immune response leading to a hypersensitivity reaction to the products. We have recently treated a 39-year-old man with hepatotoxicity resulting from a combination of a green tea-containing powder and a branched-chain amino acid supplement that was commenced 2 months previously. The hepatotoxicity resolved by stopping the consumption of these products and no other cause was detected. We decided to perform a lymphocyte toxicity assay (LTA) to determine if there was laboratory support for this diagnosis. LTA (% toxicity) represents the response of the mitochondria to toxic injury. To determine the role of the proinflammatory and anti-inflammatory cytokines and chemokines in the patient's reaction, we measured the level of cytokines and chemokine in the media of growing cells, exposed to each product or to a combination of products. The increased cytokines and chemokines are presented as the x-fold elevations from the upper limit of normal (ULN) for matrix metalloproteinase (MMP) (pg/mL × 1.5 ULN) and interleukin (IL)-1β (pg/mL × 1.8 ULN). Higher elevations were found for interferon (IFN)-β, IFN-γ, IL-8, IL 13, IL-15 (pg/mL × 2 ULN), regulated upon activation, normal T cell expressed and presumably secreted (RANTES) (pg/mL × 2 ULN), and nuclear factor (NFκB) (pg/mL × 3 ULN). The highest increases were for vascular endothelial factor (VEGF) (pg/mL × 10 ULN), tumor necrosis factor (TNF)-α, and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) (pg/mL × 13 ULN). An examination of cellular markers showed the difference between programmed cell death (apoptosis) and cell death due to necrosis. In our case, cytokeratin-ccK18 (M-30) U/L was within the normal limits, suggesting that apoptosis was normal, while ccK8(M65) U/L was elevated at 1.5 × ULN. This result implies that upon the treatment of the patient's lymphocytes with the products, the mechanism of toxicity is necrosis. In susceptible individuals, the combination of protein and herbal tea produces mitochondrial toxicity and a strong T-lymphocyte-1 response, leading to HILI. There is a need of international reporting of adverse drug reactions by clinicians, laboratories, and pharmaceutical manufacturers to drug regulatory authorities. This requires internationally accepted standard definitions of reactions, as well as criteria for assessment.

摘要

草药和辅助医学常常与传统医学相结合。我们旨在报告一例因长期饮用绿茶和蛋白奶昔导致的严重草药性肝损伤(HILI)病例。我们展示了临床和实验室证据,表明线粒体毒性和免疫反应导致了对这些产品的超敏反应。我们最近治疗了一名39岁的男性,其肝毒性由一种含绿茶的粉末和一种支链氨基酸补充剂联合引起,这两种产品在2个月前开始使用。停用这些产品后肝毒性消退,未检测到其他病因。我们决定进行淋巴细胞毒性试验(LTA),以确定该诊断是否有实验室依据。LTA(%毒性)代表线粒体对毒性损伤的反应。为了确定促炎和抗炎细胞因子及趋化因子在患者反应中的作用,我们测量了在生长细胞培养基中,暴露于每种产品或产品组合后的细胞因子和趋化因子水平。细胞因子和趋化因子升高以相对于基质金属蛋白酶(MMP)正常上限(ULN)的x倍升高表示(pg/mL×1.5 ULN)以及白细胞介素(IL)-1β(pg/mL×1.8 ULN)。干扰素(IFN)-β、IFN-γ、IL-8、IL-13、IL-15(pg/mL×2 ULN)、活化后正常T细胞表达并可能分泌的调节趋化因子(RANTES)(pg/mL×2 ULN)以及核因子(NFκB)(pg/mL×3 ULN)升高更为明显。升高最显著的是血管内皮生长因子(VEGF)(pg/mL×10 ULN)、肿瘤坏死因子(TNF)-α以及肿瘤坏死因子相关凋亡诱导配体(TRAIL)(pg/mL×13 ULN)。对细胞标志物的检查显示了程序性细胞死亡(凋亡)和坏死导致的细胞死亡之间的差异。在我们的病例中,细胞角蛋白-ccK18(M-30)U/L在正常范围内,表明凋亡正常,而ccK8(M65)U/L升高至1.5×ULN。这一结果表明,用这些产品处理患者淋巴细胞后,毒性机制是坏死。在易感个体中,蛋白质和花草茶的组合会产生线粒体毒性和强烈的T淋巴细胞1型反应,导致HILI。临床医生、实验室和制药制造商需要向药品监管机构进行国际药品不良反应报告。这需要国际上认可的反应标准定义以及评估标准。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12a2/11275310/14306b81af10/cimb-46-00448-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12a2/11275310/14306b81af10/cimb-46-00448-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12a2/11275310/14306b81af10/cimb-46-00448-g001.jpg

相似文献

1
Phytotherapy-Induced Hepatocytotoxicity: A Case Report.植物疗法诱发的肝细胞毒性:一例报告
Curr Issues Mol Biol. 2024 Jul 16;46(7):7548-7557. doi: 10.3390/cimb46070448.
2
Severe hepatocytotoxicity linked to denosumab.与地诺单抗相关的严重肝细胞毒性。
Eur Rev Med Pharmacol Sci. 2017 Mar;21(1 Suppl):78-85.
3
Biomarkers of ocular allergy and dry eye disease.眼过敏和干眼疾病的生物标志物。
Rom J Ophthalmol. 2023 Jul-Sep;67(3):250-259. doi: 10.22336/rjo.2023.42.
4
Pyrrolizidine alkaloids enhance alcohol-induced hepatocytotoxicity in vitro in normal human hepatocytes.吡咯里西啶生物碱在体外可增强酒精对正常人肝细胞的细胞毒性。
Eur Rev Med Pharmacol Sci. 2017 Mar;21(1 Suppl):53-68.
5
Valproic acid derivatives signal for apoptosis and repair in vitro.丙戊酸衍生物在体外诱导细胞凋亡和修复。
Clin Biochem. 2013 Oct;46(15):1532-7. doi: 10.1016/j.clinbiochem.2013.07.003. Epub 2013 Jul 15.
6
Suppression of NF-kappaB-dependent proinflammatory gene expression in human RPE cells by a proteasome inhibitor.蛋白酶体抑制剂对人视网膜色素上皮细胞中NF-κB依赖性促炎基因表达的抑制作用
Invest Ophthalmol Vis Sci. 1999 Feb;40(2):477-86.
7
PAPA Syndrome: Challenges in Achieving Long-Term Remission.PAPA 综合征:实现长期缓解的挑战。
Acta Dermatovenerol Croat. 2023 Nov;31(2):106-109.
8
Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13.内皮细胞对RANTES趋化因子产生的调节。IFN-γ加TNF-α的协同诱导作用以及IL-4和IL-13的抑制作用。
J Immunol. 1995 Feb 15;154(4):1870-8.
9
Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice.用于骨肉瘤治疗的间充质基质细胞:临床实践路线图。
J Bone Oncol. 2019 Mar 19;16:100231. doi: 10.1016/j.jbo.2019.100231. eCollection 2019 Jun.
10
Synergistic effect of IL-1alpha, IFN-gamma, and TNF-alpha on RANTES production by human renal tubular epithelial cells in vitro.白细胞介素-1α、干扰素-γ和肿瘤坏死因子-α对人肾小管上皮细胞体外产生调节激活正常T细胞表达和分泌因子的协同作用。
J Am Soc Nephrol. 1998 Feb;9(2):194-202. doi: 10.1681/ASN.V92194.

本文引用的文献

1
Advances in Idiosyncratic Drug-Induced Liver Injury Issues: New Clinical and Mechanistic Analysis Due to Roussel Uclaf Causality Assessment Method Use.特应性药物性肝损伤问题的研究进展:由于使用 Roussel Uclaf 因果关系评估方法,新的临床和机制分析。
Int J Mol Sci. 2023 Jun 29;24(13):10855. doi: 10.3390/ijms241310855.
2
Roussel Uclaf Causality Assessment Method for Drug-Induced Liver Injury: Present and Future.药物性肝损伤的鲁塞尔·优克福因果关系评估方法:现状与未来。
Front Pharmacol. 2019 Jul 29;10:853. doi: 10.3389/fphar.2019.00853. eCollection 2019.
3
Herb-Drug Interactions and Hepatotoxicity.
草药-药物相互作用与肝毒性。
Curr Drug Metab. 2019;20(4):275-282. doi: 10.2174/1389200220666190325141422.
4
Pyrrolizidine alkaloids enhance alcohol-induced hepatocytotoxicity in vitro in normal human hepatocytes.吡咯里西啶生物碱在体外可增强酒精对正常人肝细胞的细胞毒性。
Eur Rev Med Pharmacol Sci. 2017 Mar;21(1 Suppl):53-68.
5
Severe hepatocytotoxicity linked to denosumab.与地诺单抗相关的严重肝细胞毒性。
Eur Rev Med Pharmacol Sci. 2017 Mar;21(1 Suppl):78-85.
6
Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver Injury.药物性肝损伤的病例特征、临床特点及危险因素
Int J Mol Sci. 2016 May 12;17(5):714. doi: 10.3390/ijms17050714.
7
RUCAM in Drug and Herb Induced Liver Injury: The Update.药物及草药所致肝损伤的RUCAM:最新进展
Int J Mol Sci. 2015 Dec 24;17(1):14. doi: 10.3390/ijms17010014.
8
Development and inter-rater reliability of the Liverpool adverse drug reaction causality assessment tool.利物浦药物不良反应因果关系评估工具的开发和评分者间信度。
PLoS One. 2011;6(12):e28096. doi: 10.1371/journal.pone.0028096. Epub 2011 Dec 14.
9
Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop.药物性肝损伤命名和因果关系评估的标准化:临床研究研讨会总结。
Hepatology. 2010 Aug;52(2):730-42. doi: 10.1002/hep.23696.
10
Drug-induced liver injury: past, present and future.药物性肝损伤:过去、现在和未来。
Pharmacogenomics. 2010 May;11(5):607-11. doi: 10.2217/pgs.10.24.